Based on the largely improved affinity for FGFR1 and the simplicity of preparation we selected the tetrameric variant of FGF1-SA as a basis for development of selective cytotoxic conjugates targeting cancer cells overproducing FGFR1. Here, FGFR1 is linked to cancer.